LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
1
 24.09 27.76 1122 1461 0.7676 0.9096
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 25.79 27.76 905 1605 0.5638 0.8135
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 25.79 27.76 1037 1605 0.6461 0.8562
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 25.79 27.76 1024 1605 0.6380 0.8522
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 25.79 27.76 1134 1605 0.7065 0.8847
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 27.49 27.76 958 1723 0.5560 0.8123
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 27.49 27.76 1054 1723 0.6117 0.8416
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 27.49 27.76 1088 1723 0.6314 0.8514
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 27.49 27.76 1172 1723 0.6802 0.8747
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 29.19 27.76 990 1863 0.5314 0.8021
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 29.19 27.76 1083 1863 0.5813 0.8290
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 29.19 27.76 1123 1863 0.6027 0.8399
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 29.19 27.76 1195 1863 0.6414 0.8589
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 30.90 27.76 1029 2032 0.5063 0.7919
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 30.90 27.76 1112 2032 0.5472 0.8145
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 30.90 27.76 1170 2032 0.5757 0.8294
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 30.90 27.76 1247 2032 0.6136 0.8483
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 32.60 27.76 1044 2235 0.4669 0.7734
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 32.60 27.76 1153 2235 0.5157 0.8014
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 32.60 27.76 1156 2235 0.5170 0.8021
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 32.60 27.76 1265 2235 0.5658 0.8280
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 34.30 27.76 1082 2449 0.4417 0.7625
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 34.30 27.76 1166 2449 0.4760 0.7830
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 34.30 27.76 1185 2449 0.4837 0.7874
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 34.30 27.76 1331 2449 0.5433 0.8199
MN20160318_Q01
G04